Navigation Links
Study to explore using magnets to correct 'sunken chest'

Researchers at UCSF Children's Hospital in San Francisco have launched a groundbreaking study to determine whether a new procedure using magnets can correct sunken chest, the most common congenital chest deformity, in the same way that orthodontic braces gradually realign teeth.

Sunken chest, which is known medically as pectus excavatum, is a deformity of the cartilage that connects the ribs to the breastbone. The deformed cartilage pulls the breastbone inward, making the chest look caved in or sunken. The condition occurs in about one in 800 children born in the United States each year and is three times more common in boys than girls.

A UCSF team developed the new procedure, in which a magnet attached to the child's breastbone is coupled with a second one outside the chest that creates a steady, controlled, outward pull on the internal magnet to reshape the bone, cartilage and chest wall.

The procedure marks one of the first times magnets have been embedded inside the body to treat a health condition, according to Michael Harrison, MD, professor of surgery and pediatrics emeritus at UCSF and lead investigator of the study.

"We needed to apply a force to gradually remodel the chest wall without piercing the skin," Harrison said. "Magnets do it."

The research team named the new technique the "Magnetic Mini-Mover Procedure," known as 3MP. The 3MP uses a device that includes two parts: a titanium-encased magnet about the size of a quarter that is surgically attached to the child's breastbone and a second magnet embedded in a lightweight plastic brace that the child wears under clothing. The attraction between the two magnets holds the brace in place.

Because the internal magnet is placed just under the skin during an outpatient visit, the child can go home on the day of the procedure with relatively little discomfort. The child wears the brace for three to 12 months, depending on the severity of the deformit y. It can be adjusted to increase or decrease the pull on the breastbone in the same way that orthodontic braces are loosened or tightened.

If successful, the 3MP could revolutionize treatment of pectus excavatum, according to Harrison. Current approaches to correcting sunken chest involve major surgery to open and rebuild the chest and the insertion of metal struts to hold the chest in place while it heals. Complications can occur because the struts are under significant pressure, and the painful recovery can take months.

"The problem with present techniques is that they attempt to reshape the chest wall in one big operation," Harrison said. "A better idea is to apply a little force over a longer time, like the orthodontist moves your teeth."

The use of the magnets has been deemed safe by the U.S. Food and Drug Administration, which has reviewed and approved the 3MP device. The internal magnet is laser-welded in a titanium case, assuring its safety. The magnets have been found to have no effect on the heart or other body parts, and studies have demonstrated that long-term exposure to magnetic fields is not harmful.

Sunken chest had long been considered a cosmetic defect. But recent studies have determined that while not life-threatening, in severe cases the deformity can cause heart and breathing difficulties, because the abnormal breast bone can reduce blood flow to the heart and prevent the lungs from expanding completely, restricting the ability to exercise, according to Harrison. Some patients also suffer serious emotional difficulties and low self-esteem, especially since sunken chest often worsens during adolescence when children are self-conscious about their appearance and seek peer acceptance.

"This is not a trivial problem for these kids," Harrison said. "Most are willing to undergo a big, painful and expensive surgery to fix it. Why not a simple little outpatient procedure to fix it?"

Research ers are seeking potential study participants who have sunken chest and are between 8 and 14 years of age, otherwise healthy and willing to participate in the 12-month-long study of the new procedure.


'"/>

Source:University of California - San Francisco


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... December 05, 2016 , ... In anticipation of AxioMed’s exclusive ... production, company President, Jake Lubinski will be traveling to Germany on December 6th. ... Cologne and Karlsruhe to discuss the benefits of a viscoelastic total disc replacement. ...
(Date:12/5/2016)... , Dec. 5, 2016  Eisai Inc. ... open-label two-year study of rufinamide, which were presented ... Epilepsy Society (AES) held from December 2-6 in ... final two-year safety, tolerability and cognitive data showed ... experienced similar safety and tolerability profiles, cognitive development ...
(Date:12/4/2016)... 2016  In five studies being presented today during ... and Exposition in San Diego , ... the delivery of life-saving treatments to patients with a ... to carry therapies directly to the sites in the ... a substantial advantage over traditional, systemic methods. The studies ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
Breaking Biology Technology: